CONSULTANTS
Matthew Augustine, Ph.D. |
Topical and Oral Product Formulation and Manufacturing |
| Dennis E. Babel, Ph.D., (ABB) |
Clinical Microbiology |
| Charles Bon | Biostatistics and Pharmacokinetics Services |
| H. Joseph Cardenas | Site Audits for Bio Studies & Clinical Studies, Spanish Interpreter and Translator |
| Alex El-Beidi | Controlled Substance DEA Compliance |
| Ron Filler, Ph.D. | Designs Pharmacology and Toxicology Studies and Literature Review |
| Ulrike (Uli) Foley | Sales Marketing & BD in Pharmaceutical, Medical Device, Diagnostic, CRO & Biotech Industries |
| Jean L. Fourcroy, M. D. | Regulatory and Compliance consulting for Drug and Devices |
| Mike Jarvill | Preparation of Submissions to the European Union |
| Isadore (Izzy) Kanfer | Emeritus Professor of Pharmaceutics |
| Linda Magill | Quality Systems and Regulatory Compliance for Drugs and Devices |
| Robert Mazzaferro | Medical Device Reviewer/Engineer |
| Jairaj (Jai) Mehta | GMP, GCP and GLP Compliance, Sterile Products Specialist |
| Ramakant M. Mhatre, Ph.D. |
Pharmacology and Toxicology Reviews, FDA Liasion |
| Robert Milanese | Strategic Business Planning and Product Licensing |
| Barrie M. Phillips, Ph.D. | Clinical Research, Topical BE with Clinical Endpoint and Topical BA |
| Lynn Kennard Pershing, Ph.D. | Design and Evaluation of Pre-clinical In Vitro Studies |
| Leon Shargel, Ph.D., R.Ph. | CE and BE Protocol Preparation, Pharmacology and Toxicology Consulting |
| Humphrey Tebit | Clinical Study Design and Statistical Analysis |
| Robert L. Zeid | Regulatory Affairs, Quality Assurance and Technical Writing Specialist |
"Specialists in 505(b)(2) NDA/ANDA/Regulatory and Development Services"
We invite you to contact us about your drug development needs, as well as our cGMP, cGCP and cGLP inspections and auditing services. We can build a foundation for your product development needs.
CONTACT US
RRI Group, Inc.
248 Latitude Lane, Suite 104
Lake Wylie, SC 29710
Phone: 803-831-7657
Fax: 803-831-1494
email
"Specialists in 505(b)(2) NDA/ANDA/Regulatory & Development Services"
Trends in 505(b)(2)Approvals
By Loren Gelber, Chief Scientific Officer at RRI Group, Inc
"Highway to Higher Profits"
SPA Symposium, Baltimore MD:
Call RRI to learn more! 803.831.7657
» more
